Search research articles
Contact Us
Filters
Showing results (361-370 of 377) with videos related to
Page
of 38
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
January 5, 2023
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 15, 2025
The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 <sup>68</sup>Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic accuracy compared to histopathology and their impact on patient management
Frederik L Giesel, Stefan A Koerber, Boris Hadaschik, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 19, 2022
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysis
Simon K B Spohn, Andrea Farolfi, Sarah Schandeler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 29, 2023
Joint EANM/SNMMI procedure guideline for the use of <sup>177</sup>Lu-labeled PSMA-targeted radioligand-therapy (<sup>177</sup>Lu-PSMA-RLT)
Clemens Kratochwil, Wolfgang P Fendler, Matthias Eiber, et al.
European Urology
|
September 13, 2025
SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis
Ken Herrmann, Jochen Walz, Steven MacLennan, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 17, 2023
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy
Simon K B Spohn, Nina-Sophie Schmidt-Hegemann, Juri Ruf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 16, 2020
Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline
Edouard J Trabulsi, R Bryan Rumble, Hossein Jadvar, et al.
The Lancet. Oncology
|
December 4, 2018
Consensus on molecular imaging and theranostics in prostate cancer
Stefano Fanti, Silvia Minozzi, Gerald Antoch, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 6, 2022
Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After Prostatectomy
Constantinos Zamboglou, Iosif Strouthos, Joerg Sahlmann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
July 14, 2021
Value of PET imaging for radiation therapy
Constantin Lapa, Ursula Nestle, Nathalie L Albert, et al.
Page
of 38
Search research articles
Search
Showing results (361-370 of 377) with videos related to
Sort By:
Page
of 38
European Journal of Nuclear Medicine and Molecular Imaging
|
January 5, 2023
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 15, 2025
The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 <sup>68</sup>Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic accuracy compared to histopathology and their impact on patient management
Frederik L Giesel, Stefan A Koerber, Boris Hadaschik, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 19, 2022
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysis
Simon K B Spohn, Andrea Farolfi, Sarah Schandeler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 29, 2023
Joint EANM/SNMMI procedure guideline for the use of <sup>177</sup>Lu-labeled PSMA-targeted radioligand-therapy (<sup>177</sup>Lu-PSMA-RLT)
Clemens Kratochwil, Wolfgang P Fendler, Matthias Eiber, et al.
European Urology
|
September 13, 2025
SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis
Ken Herrmann, Jochen Walz, Steven MacLennan, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 17, 2023
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy
Simon K B Spohn, Nina-Sophie Schmidt-Hegemann, Juri Ruf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 16, 2020
Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline
Edouard J Trabulsi, R Bryan Rumble, Hossein Jadvar, et al.
The Lancet. Oncology
|
December 4, 2018
Consensus on molecular imaging and theranostics in prostate cancer
Stefano Fanti, Silvia Minozzi, Gerald Antoch, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 6, 2022
Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After Prostatectomy
Constantinos Zamboglou, Iosif Strouthos, Joerg Sahlmann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
July 14, 2021
Value of PET imaging for radiation therapy
Constantin Lapa, Ursula Nestle, Nathalie L Albert, et al.
Page
of 38